Literature DB >> 474159

Sotalol intoxication, two patients with concentration-effect relationships.

P J Neuvonen, E Elonen, L Tarssanen.   

Abstract

Two adult patients ingested an overdose of 2.4 g and 8.0 g of sotalol hydrochloride, respectively, i.e. 7-25 times the mean daily dose. Certain signs as bradycardia and hypotension were similar to those described for other beta-blocking agents. In addition to these, however, both patients had severe cardiac tachyarrhythmias and a considerably prolonged QT-interval in their electrocardiogram. The decline of serum sotalol concentrations followed first-order kinetics with the elimination half-life of 13-15 hours. There was a good correlation between the serum sotalol concentration and the prolongation of the QT-interval. Sotalol differs from other beta-blocking agents in its effects on the action potential of the ventricular muscle and Purkinje fibers of the heart. This is likely to explain the different symptoms and findings of sotalol intoxication compared to those seen in connection with other beta-blocking agents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 474159     DOI: 10.1111/j.1600-0773.1979.tb02360.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  7 in total

Review 1.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

2.  The role of concentration--effect relationships in the QTc interval prolongation: case sotalol.

Authors:  Pertti J Neuvonen; Erkki Elonen
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

3.  [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].

Authors:  M Karch; C Schmitt; A Plewan; G Schmidt; A Schömig
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

4.  Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication.

Authors:  P J Neuvonen; E Elonen; T Vuorenmaa; M Laakso
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 5.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 6.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 7.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.